Status:
COMPLETED
PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration
Lead Sponsor:
University Hospital of Patras
Collaborating Sponsors:
St. Andrew's General Hospital, Patras, Greece
Conditions:
Adjacent Segment Degeneration
Eligibility:
All Genders
49-71 years
Phase:
NA
Brief Summary
A retrospective study that aims to report Adjacent Segment Degeneration (ASD) incidence and spinopelvic balance in short lumbosacral instrumentation for degenerative lumbar spinal stenosis. Although A...
Detailed Description
Methods From 55 consecutive age-, diagnosis- and gender- matched patients aged 60±11 years, 17 (Group R) received PEEK IS; 18 (Group S) received Silicon IS and compared with 20 controls (Group C) with...
Eligibility Criteria
Inclusion
- Preoperative MRI with degeneration grades\<III at the 1st supradjacent lumbar segment.
Exclusion
- Body mass index≥40kg/m\*m
- Severe osteoporosis
- Lumbar fracture
- Preoperative SVA\>4cm
- Spondylolisthesis grades\>II or spondylolytic lesion and acquired spinous process insufficiency in the supradjacent segment cephalad to instrumentation
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT03477955
Start Date
April 1 2006
End Date
November 1 2009
Last Update
April 10 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.